Evidence map›Paper›PMID 41590808›Full record

ReviewJournal of functional biomaterials2026

Allomelanin: A Promising Alternative to Polydopamine for Bioapplications.

Silvia Vicenzi, Agata Pane, Chiara Mattioli, Dario Mordini, Arianna Menichetti, Marco Montalti

Abstract readReview
In one paragraph

Review in Journal of functional biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Silvia VicenziDepartment of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.
Agata PaneDepartment of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.ORCID 0009-0008-2735-7911
Chiara MattioliDepartment of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.
Dario MordiniDepartment of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.ORCID 0000-0002-8084-4638
Arianna MenichettiDepartment of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.ORCID 0000-0003-0895-4776
Marco MontaltiDepartment of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.ORCID 0000-0001-6227-0899

Funding

Ministero dell'università e della ricerca PRIN 2022 PNRR, Nanotherm, grant number P20224N3WK
6 · The paper itself

Abstract

Allomelanin is a natural class of melanin found mainly in fungi and derived from nitrogen-free precursors such as 1,8-dihydroxynaphthalene (1,8-DHN). Despite its biological relevance, allomelanin remains significantly less explored than other synthetic melanin analogs, particularly compared to polydopamine, a synthetic analog of eumelanin. In this review, we provide a comprehensive overview of current knowledge on allomelanin, summarizing the main methods used to characterize its molecular structure, morphology, and chemical functionalities. We also present its emerging applications, ranging from human health to materials science, highlighting how its optical characteristics, ability to modulate redox processes, and antioxidant properties support its growing technological interest. Finally, we describe the natural presence and biological role of allomelanin, highlighting how knowledge of its biosynthetic processes and functions in nature can guide more effective strategies for the design and optimization of new allomelanin materials.

Indexed as

1,8-DHNantioxidantfungimelanin-like nanoparticlesnanomedicinePDHNphotothermalPTTradicalsROS

Identifiers

PMID41590808
PMCPMC12842502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.